Showing results (821-830 of 1,006) with videos related to

Sort By:
Pageof 101
Alimentary Pharmacology & Therapeutics|April 1, 2006
Predictors of the placebo response in functional dyspepsiaN J Talley, G R Locke, B D Lahr, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 10, 2007
Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control studyNicholas J Talley, Marjorie M Walker, Pertti Aro, et al.
The American Journal of Gastroenterology|April 1, 1996
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trialsS J Veldhuyzen van Zanten, C Cleary, N J Talley, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2007
The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-siteS J Crane, G Richard Locke, W S Harmsen, et al.
The American Journal of Gastroenterology|April 27, 2007
Subsite-specific risk factors for esophageal and gastric adenocarcinomaSarah J Crane, G Richard Locke, William S Harmsen, et al.
Clinical and Translational Gastroenterology|July 26, 2019
The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated DysbiosisAdam Carstens, Johan Dicksved, Ronald Nelson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 18, 2005
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disordersA M Rentz, P Kahrilas, V Stanghellini, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled studyS V van Zanten, N Flook, N J Talley, et al.
Neurogastroenterology and Motility|June 15, 2007
A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndromeY A Saito, G R Locke, J M Zimmerman, et al.
Alimentary Pharmacology & Therapeutics|February 9, 2019
Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel diseaseAyesha Shah, Mark Morrison, Daniel Burger, et al.
Pageof 101